A detailed history of Utah Retirement Systems transactions in Incyte Corp stock. As of the latest transaction made, Utah Retirement Systems holds 26,329 shares of INCY stock, worth $1.81 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
26,329
Previous 30,529 13.76%
Holding current value
$1.81 Million
Previous $1.85 Million 5.95%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $240,786 - $288,162
-4,200 Reduced 13.76%
26,329 $1.74 Million
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $66,534 - $82,875
-1,300 Reduced 4.08%
30,529 $1.85 Million
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $10,432 - $12,838
200 Added 0.63%
31,829 $2 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $5,777 - $6,593
100 Added 0.32%
31,629 $1.83 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $60,950 - $75,510
-1,000 Reduced 3.07%
31,529 $1.96 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $14,046 - $17,202
200 Added 0.62%
32,529 $2.35 Million
Q4 2022

Feb 15, 2023

SELL
$67.18 - $84.11 $40,308 - $50,466
-600 Reduced 1.82%
32,329 $2.6 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $13,236 - $16,572
200 Added 0.61%
32,929 $2.19 Million
Q2 2022

Aug 16, 2022

SELL
$66.18 - $83.18 $13,236 - $16,636
-200 Reduced 0.61%
32,729 $2.49 Million
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $39,612 - $47,825
-600 Reduced 1.79%
32,929 $2.62 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $6,334 - $7,411
100 Added 0.3%
33,529 $2.46 Million
Q3 2021

Nov 16, 2021

SELL
$68.67 - $84.02 $123,606 - $151,236
-1,800 Reduced 5.11%
33,429 $2.3 Million
Q2 2021

Aug 16, 2021

SELL
$79.87 - $87.53 $7,987 - $8,753
-100 Reduced 0.28%
35,229 $2.96 Million
Q1 2021

May 17, 2021

SELL
$76.02 - $100.5 $83,622 - $110,550
-1,100 Reduced 3.02%
35,329 $2.87 Million
Q4 2020

Feb 16, 2021

BUY
$80.74 - $97.7 $129,183 - $156,320
1,600 Added 4.59%
36,429 $3.17 Million
Q3 2020

Nov 16, 2020

BUY
$85.07 - $109.69 $17,014 - $21,938
200 Added 0.58%
34,829 $3.13 Million
Q2 2020

Aug 13, 2020

BUY
$74.18 - $108.93 $51,926 - $76,251
700 Added 2.06%
34,629 $3.6 Million
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $6,318 - $8,597
100 Added 0.3%
33,929 $2.49 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $21,845 - $25,956
300 Added 0.89%
33,829 $2.51 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $31,540 - $38,052
429 Added 1.3%
33,529 $2.85 Million
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $25,424 - $35,268
400 Added 1.22%
33,100 $2.85 Million
Q4 2018

Feb 08, 2019

BUY
$58.5 - $69.94 $5,850 - $6,994
100 Added 0.31%
32,700 $2.08 Million
Q3 2018

Nov 13, 2018

BUY
$61.75 - $74.23 $6,175 - $7,423
100 Added 0.31%
32,600 $2.25 Million
Q2 2018

Aug 10, 2018

BUY
$60.85 - $83.98 $12,170 - $16,796
200 Added 0.62%
32,500 $2.18 Million
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $140,340 - $174,900
1,500 Added 4.87%
32,300 $3.06 Million
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $3.36 Million - $4.26 Million
30,800
30,800 $3.6 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.